EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Statin-related Muscle Toxicity: An Evidence-based Review

Mohammad S Jeeyavudeen, Joseph M Pappachan, Ganesan Arunagirinathan

European Endocrinology · 2022 · 18 (2) · 89

DOI: 10.17925/ee.2022.18.2.89 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Endocrinology, 2022. Verfasst von Mohammad S Jeeyavudeen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Western General Hospital, Edinburgh Centre for Endocrinology Diabetes, Edinburgh, UK. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: This article is published under the Creative Commons Attribution Non-commercial License..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The efficacy of statins in the primary and secondary prevention of cardiovascular disease has been proven beyond doubt. The number needed to treat to prevent one cardiovascular event is 1 in 30 over 10 years, and the number needed to treat for secondary prevention is much lower. However, a recent study demonstrated that only 68% of eligible patients are on statin therapy. Moreover, there seems to be a reluctance to escalate statin doses due to the fear of adverse effects. The adverse effects that worries patients and their physicians most frequently are those related to muscular symptoms. N-of-1 trial evidence suggests that muscular symptoms attributed to statins are often caused by the nocebo effect. This article aims to provide a structured, evidence-based approach to suspected statin-related muscle toxicity.

Schlagwörter

Stichwörter der Autor:innen

Cardiovascular riskcreatine kinasestatin-associated muscle symptomsstatin-related muscle toxicitystatins

Autor:innen und Institutionen

  • Western General Hospital, Edinburgh Centre for Endocrinology Diabetes, Edinburgh, UK.
  • Lancashire Teaching Hospitals NHS Trust, Lancashire, UK.
  • Manchester Metropolitan University, Manchester, UK.

Förderung

  • This article is published under the Creative Commons Attribution Non-commercial License.

Zitieren

APA

Jeeyavudeen, M. S., Pappachan, J. M., & Arunagirinathan, G. (2022). Statin-related Muscle Toxicity: An Evidence-based Review. European Endocrinology, 18(2), 89. https://doi.org/10.17925/ee.2022.18.2.89

Vancouver

Jeeyavudeen MS, Pappachan JM, Arunagirinathan G. Statin-related Muscle Toxicity: An Evidence-based Review. European Endocrinology. 2022;18(2):89. doi:10.17925/ee.2022.18.2.89

BibTeX
@article{Jeeyavudeen2022,
  author = {Jeeyavudeen, Mohammad S and Pappachan, Joseph M and Arunagirinathan, Ganesan},
  title = {Statin-related Muscle Toxicity: An Evidence-based Review},
  journal = {European Endocrinology},
  year = {2022},
  volume = {18},
  number = {2},
  pages = {89},
  doi = {10.17925/ee.2022.18.2.89}
}
Kostenlos starten →